Skip to content
NP FADY

Sleep

CBD for Anxiety and Sleep: What We Know, What We Don't

Curious whether CBD can ease anxiety or help you sleep? Here is an honest look at what the research actually shows, what it does not, and how to think it through safely. That includes the proven options worth considering first and the questions to ask your clinician or pharmacist before you try anything.

Originally published January 3, 2026

Last reviewed June 2, 2026

Clinical review: Fady Boules, PMHNP-BC

Introduction: Why This Matters Now

More people are asking about cannabidiol (CBD) for worry and sleepless nights. In May 2024, the CDC reported that 30 to 46 percent of U.S. adults are not getting enough sleep, depending on the state. Sleep loss like this affects mood, focus, and health. Meanwhile, the FDA (July 2024) reaffirmed that CBD is not approved as a dietary supplement or food and that safety questions remain, even as products are widely sold.

In the Inland Empire, including Redlands, CBD products are easy to find. California permits retail sales of many hemp-derived CBD items under AB 45, and 2024 emergency rules added age-21 restrictions and a “no detectable THC per serving” standard for hemp foods and supplements.

What We Know (and Don’t) About CBD for Anxiety and Sleep

What Is CBD, Plain and Simple

CBD (cannabidiol) is a non-intoxicating compound from the cannabis plant. It is not the same as THC (tetrahydrocannabinol), the compound that causes a “high.” Over-the-counter CBD products are not FDA-approved to treat anxiety or insomnia. The only FDA-approved CBD medicine is Epidiolex, which is approved for certain seizure types.

How might CBD work? CBD interacts with serotonin (5-HT1A) receptors and the endocannabinoid system, which help regulate stress, mood, and sleep. The evidence in humans is still developing.

What Does the Evidence Say for Anxiety?

Systematic reviews and meta-analyses from 2024 suggest CBD may reduce anxiety symptoms, but the trials are small, use different doses, and produce mixed results:

  • One 2024 meta-analysis (8 studies, 316 participants) found a moderate-to-large effect but cautioned about limited sample sizes and methods.
  • A 2024 review of randomized trials reported conflicting outcomes overall.
  • A 2024 randomized trial in JAMA Network Open, in women with advanced breast cancer, tested a single oral CBD dose. The main result was negative, but anxiety levels after the dose were lower than placebo at two to four hours. That is a signal, not proof.

Bottom line for anxiety: CBD shows some promise, but we lack large, well-designed trials in primary anxiety disorders, a standard dose, and long-term safety data.

What Does the Evidence Say for Sleep and Insomnia?

A 2024 randomized, placebo-controlled pilot trial of nightly CBD for primary insomnia found mixed and mostly neutral effects on sleep. Some well-being measures improved, but CBD did not clearly outperform placebo on the core sleep measures.

Broader reviews conclude that cannabinoids are not ready for routine insomnia care, citing limited, inconsistent evidence and potential downsides.

Bottom line for sleep: the evidence is inconclusive. A few small trials suggest possible benefit for some people; many show no meaningful difference from placebo.

What This Means for You

If you live in Redlands or the wider Inland Empire and you are considering CBD for anxiety or sleep, know that the science is emerging, not definitive. CBD might help some people, but it is not a first-line treatment. We usually start with proven therapies (see the Alternatives section below), then consider CBD case by case, especially if you have side-effect concerns or prefer to avoid sedatives. We also check for drug interactions and talk through product quality.

CBD is not a cure-all. For some people it may be a useful add-on, but only after the basics are covered: an accurate diagnosis, proven therapies, and safety checks.

Safety, Interactions, and Quality Basics

Key Safety Considerations

Liver and drug interactions: Prescription CBD (Epidiolex) can raise liver enzymes and interacts with the CYP3A4 and CYP2C19 pathways. Use caution with medicines such as:

  • Clobazam and diazepam
  • Some SSRIs and SNRIs
  • Tricyclic antidepressants
  • Antiepileptic medicines
  • Warfarin

Monitoring may be needed.

Pregnancy and breastfeeding: The FDA advises against CBD during pregnancy or lactation because of the unknowns, and the CDC discourages use.

Product quality: Mislabeling is common. A 2022 JAMA Network Open study of CBD topical products found that 76 percent were inaccurately labeled, and THC was detected in 35 percent.

Drug testing: Pure CBD is not what tests screen for, but full-spectrum or contaminated products can trigger a THC-positive urine test. This has been seen after four weeks of using a hemp CBD oil in an open-label study. Employers follow federal and safety-sensitive rules for THC, not CBD.

If You Are Considering CBD

If you and your clinician are weighing CBD, these steps can help you do it safely:

  • Start with a diagnosis. Anxiety and insomnia are treatable, and it helps to rule out sleep apnea, thyroid issues, trauma, or medication effects first.
  • Review proven options first, such as CBT-I, CBT, and SSRIs or SNRIs (see the Alternatives section).
  • Check interactions with your clinician or pharmacist, and bring a full list of your medications and supplements.
  • Choose products with a recent COA (Certificate of Analysis) from an ISO-accredited lab. It is safer to avoid products without batch testing or that list only a “proprietary blend.”
  • Use caution if you have liver disease, and avoid CBD if you are pregnant or breastfeeding.
  • If you decide to try it, agreeing on a short trial window with clear goals (such as how quickly you fall asleep, night-time awakenings, and daytime anxiety) can help you tell whether it is actually helping.
  • Be mindful of driving and sedation until you know how it affects you.
  • If you are drug-tested for work, broad-spectrum or isolate products with non-detectable THC carry less risk, though some risk remains.
  • Keep all cannabis products away from children and pets, and store them locked.

Myths vs. Facts

MythFact
"CBD is proven to treat anxiety."The evidence suggests possible benefit, but the trials are small and mixed. It is not yet a first-line treatment.
"CBD cures insomnia."A 2024 randomized controlled trial showed no clear advantage over placebo for core sleep outcomes.
"CBD will never affect a drug test."Full-spectrum or contaminated products can produce a THC-positive result.
"CBD does not interact with medicines."CBD can raise or lower the levels of many drugs through CYP enzymes, so monitoring may be needed.
"All CBD labels are accurate."Mislabeling is common, and THC has been found in products labeled THC-free.

Risks, Limitations, and Uncertainties

Regulatory Gaps

At the federal level, CBD is not approved as a supplement or food, and labeling and purity vary widely. California’s AB 45 and the 2024 emergency rules improve the guardrails but do not guarantee quality.

Side Effects and Interactions

  • Sleepiness
  • Diarrhea
  • Appetite changes
  • Liver enzyme elevations at higher doses
  • Real drug-to-drug interactions

Evidence Quality

The trials are small, the products and doses differ from study to study, and follow-up is short. Expectancy and placebo effects are notable in anxiety studies.

Alternatives and Adjacent Options (Evidence-Based)

For Anxiety

First-line treatments with strong evidence include:

  • Cognitive Behavioral Therapy (CBT)
  • SSRIs and SNRIs (selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors)
  • Lifestyle strategies such as exercise, mindfulness, and sleep hygiene

For Insomnia

CBT-I (Cognitive Behavioral Therapy for Insomnia) is the first-line treatment. It typically runs four to eight sessions and is available in person or digitally. If needed, short-term sleep medicines can be considered with monitoring.

If CBD Is Tried

Treat it as an add-on, with clear goals, safety checks, and a stop date.

Local note (Redlands and the Inland Empire): Our mental-health and psychiatric care team can coordinate CBT and CBT-I referrals, monitor interactions, and help you navigate California’s product rules.

  • What to expect at your first anxiety visit
  • Insomnia basics and CBT-I
  • Medication options for anxiety, with pros and cons

Frequently Asked Questions

Hemp-derived CBD products can be sold under AB 45, with 2024 emergency rules adding age-21 limits and a no-detectable-THC-per-serving standard for foods and supplements. Federal law still does not approve CBD as a supplement.

Will CBD show up on a drug test?

Tests target THC, not CBD. But full-spectrum or contaminated CBD can lead to a THC-positive test, even with otherwise compliant products, so the risk cannot be reduced to zero.

What dose have studies used?

Research doses vary widely and are often much higher than the amounts found in many store-bought products. That is one reason study results do not map neatly onto over-the-counter CBD, and it is part of why there is no established standard dose for anxiety or sleep. This is a good thing to discuss with your clinician.

Is CBD safe with my antidepressant or sleep medicine?

Sometimes, but not always. CBD can interact with the CYP3A4 and CYP2C19 pathways and raise the levels of some medications. Your clinician may adjust a dose or order labs.

What about cost, coverage, and access in Redlands and the Inland Empire?

Over-the-counter CBD is not typically covered by insurance, and prices vary by brand and product. Evidence-based treatments such as CBT-I, therapy, and medication for anxiety are often covered. Our team can check your benefits and offer lower-cost options or digital CBT-I when available.

Key Takeaways

  • The evidence is promising but limited for anxiety, and inconclusive for sleep.
  • Quality and labeling vary, so look for a COA and understand the drug-testing risk.
  • Safety comes first: watch for liver enzyme elevations and drug interactions.
  • Start with proven care (CBT, CBT-I, SSRIs or SNRIs) and consider CBD only as an add-on.
  • California rules add guardrails, but federal approval as a supplement is still absent.

If you remember only one thing: talk with a clinician about evidence-based options first, and if you try CBD, do it safely, transparently, and with a plan.

References

  1. CDC. FastStats: Sleep in Adults (state-level insufficient sleep). 2024. https://www.cdc.gov/sleep/data-research/facts-stats/adults-sleep-facts-and-stats.html
  2. U.S. FDA. FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD). 2024. https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd
  3. California Department of Public Health. Emergency Regulations for Industrial Hemp. 2024-2025. https://www.cdph.ca.gov/Programs/OLS/Pages/DPH-24-005E-Emergency-Regulations-for-Industrial-Hemp.aspx
  4. Han K. Therapeutic potential of cannabidiol (CBD) in anxiety disorders: a meta-analysis. Psychiatry Research, 2024. https://pubmed.ncbi.nlm.nih.gov/38924898/
  5. de Faria Coelho C. The impact of cannabidiol treatment on anxiety disorders: a systematic review of RCTs. Life (MDPI), 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11595441/
  6. Nayak MM, et al. Cannabidiol for scan-related anxiety in women with advanced breast cancer: a randomized clinical trial. JAMA Network Open, 2024. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2828077
  7. Narayan AJ, et al. Cannabidiol for moderate-to-severe insomnia: a randomized controlled pilot trial. J Clin Sleep Med, 2024. https://pubmed.ncbi.nlm.nih.gov/38174873/
  8. AASM. Cannabis and Sleep Disorders: What Clinicians Need to Know. 2024. https://aasm.org/viewpoints-cannabis-and-sleep-disorders-what-clinicians-need-to-know/
  9. Epidiolex (cannabidiol) Prescribing Information. 2024. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210365s021lbl.pdf
  10. LiverTox, NIH. Cannabidiol. Updated 2023. https://www.ncbi.nlm.nih.gov/books/NBK548890/
  11. U.S. FDA. What You Should Know About Using Cannabis, Including CBD, When Pregnant or Breastfeeding. Consumer Update. https://www.fda.gov/consumers/consumer-updates/what-you-should-know-about-using-cannabis-including-cbd-when-pregnant-or-breastfeeding
  12. CDC. About CBD. 2025. https://www.cdc.gov/cannabis/about/about-cbd.html
  13. Spindle TR, et al. Cannabinoid content and label accuracy of hemp-derived topical products. JAMA Network Open, 2022. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2794440
  14. Dahlgren MK, et al. Urinary THC after four weeks of full-spectrum, high-CBD treatment. JAMA Psychiatry, 2021. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2772629
  15. SAMHSA. Medical Review Officer Guidance Manual. 2024. https://www.samhsa.gov/sites/default/files/mro-guidance-manual-2024.pdf
  16. U.S. FDA. FDA Concludes Existing Regulatory Frameworks for Foods and Supplements Are Not Appropriate for Cannabidiol. 2023. https://www.fda.gov/news-events/press-announcements/fda-concludes-existing-regulatory-frameworks-foods-and-supplements-are-not-appropriate-cannabidiol
  17. Zhekova AM, et al. Expectancy effects on cannabidiol treatment of anxiety disorders. Cannabis and Cannabinoid Research, 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC10851629/
  18. Garakani A, et al. Pharmacotherapy of anxiety disorders: current and emerging treatment options. Front Psychiatry, 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7786299/
  19. Edinger JD, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults. J Clin Sleep Med, 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC7853203/
  20. 988 Suicide and Crisis Lifeline. https://988lifeline.org/
  21. San Bernardino County Department of Behavioral Health. Access and Crisis Lines. 2024-2025. https://wp.sbcounty.gov/dbh/

If you or someone you know is in crisis

  • Call 911 or go to your nearest emergency room for any life-threatening emergency.
  • 988 Suicide & Crisis Lifeline — call or text 988, available 24/7. En español: marque 988 y oprima 2. Veterans: 988 y oprima 1, or text 838255.
  • Crisis Text Line — text HOME to 741741.
  • The Trevor Project (crisis support for LGBTQ+ young people) — call 1-866-488-7386, or text START to 678-678.
  • Riverside County — 24/7 crisis line 951-686-HELP (4357); CARES line 800-499-3008.
  • San Bernardino County — DBH Screening/Referral 800-968-2636; DBH ACCESS 888-743-1478 (24/7); Mobile Crisis/CCRT 800-398-0018; crisis text 909-420-0560. Arrowhead Regional Medical Center (ARMC) has a dedicated adolescent psychiatric ER (ages 13–17).
  • NP Fady (non-emergency) — for routine scheduling or questions, call (909) 707-6261. This line is not monitored for emergencies.